Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.

Literature DB >> 3346696

Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.

Abstract

A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1988 PMID： 3346696 PMCID： PMC1031546 DOI： 10.1136/jnnp.51.2.285

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

14 in total

1. Epilepsy and disseminated sclerosis.

Authors: W B MATTHEWS
Journal: Q J Med Date: 1962-04

2. The effect of massive pulse steroid therapy on the water content of the rat brain.

Authors: J Cerilli; J A Miller
Journal: Transplantation Date: 1972-09 Impact factor: 4.939

3. Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppresive therapy.

Authors: S S Stubbs; R M Morrell
Journal: Transplant Proc Date: 1973-06 Impact factor: 1.066

4. Cyclosporin A, methylprednisolone, and convulsions.

Authors: S Durrant; P M Chipping; S Palmer; E C Gordon-Smith
Journal: Lancet Date: 1982-10-09 Impact factor: 79.321

5. Fatal arrhythmia after pulse methylprednisolone therapy.

Authors: R E Moses; A McCormick; W Nickey
Journal: Ann Intern Med Date: 1981-12 Impact factor: 25.391

6. Methylprednisolone therapy in multiple sclerosis.

Authors: P K Newman; M Saunders; P J Tilley
Journal: J Neurol Neurosurg Psychiatry Date: 1982-10 Impact factor: 10.154

7. Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis.

Authors: E S Cathcart; B A Idelson; M A Scheinberg; W G Couser
Journal: Lancet Date: 1976-01-24 Impact factor: 79.321

8. Methylprednisolone pulse therapy in the treatment of polyarteritis nodosa.

Authors: G H Neild; H A Lee
Journal: Postgrad Med J Date: 1977-07 Impact factor: 2.401

9. A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease.

Authors: I A Williams; E M Baylis; M E Shipley
Journal: Lancet Date: 1982-07-31 Impact factor: 79.321

10. Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis.

Authors: P C Dowling; V V Bosch; S D Cook
Journal: Neurology Date: 1980-07 Impact factor: 9.910

16 in total

1. VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis.

Authors: Blythe C Dillingham; Susan M Knoblach; Gina M Many; Brennan T Harmon; Amanda M Mullen; Christopher R Heier; Luca Bello; John M McCall; Eric P Hoffman; Edward M Connor; Kanneboyina Nagaraju; Erica K M Reeves; Jesse M Damsker
Journal: Cell Mol Neurobiol Date: 2014-11-13 Impact factor: 5.046

2. New-onset acute heart failure after intravenous glucocorticoid pulse therapy in a patient with Graves' ophthalmopathy.

Authors: Alptekin Gursoy; Mustafa Cesur; Murat Faik Erdogan; Demet Corapcioglu; Nuri Kamel
Journal: Endocrine Date: 2006-06 Impact factor: 3.633

3. Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone.

Authors: A M Humm; W J Z'Graggen; R Bühler; M R Magistris; K M Rösler
Journal: J Neurol Neurosurg Psychiatry Date: 2005-09-20 Impact factor: 10.154

4. Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.

Authors: Matthew E Sweeney; Joyce G Slusser; Sharon G Lynch; Stephen H Benedict; Sharon L Garcia; Laura Rues; Steven M LeVine
Journal: Int Immunopharmacol Date: 2011-07-30 Impact factor: 4.932